Camden Capital, LLC Roivant Sciences Ltd. Put Options Transaction History
Camden Capital, LLC
- $887 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
334Shares Held
515MCall Options Held
1.13MPut Options Held
1.26M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$689 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$688 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$565 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$461 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$370 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.36B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...